TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioEndev AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
180
|
42
|
50 |
| Financial expenses |
12
|
10
|
17 |
| Earnings before taxes |
-91
|
-954
|
-3,211 |
| EBITDA |
-112
|
-944
|
-2,609 |
| Total assets |
3,015
|
4,896
|
939 |
| Current assets |
2,880
|
4,750
|
442 |
| Current liabilities |
396
|
1,116
|
67 |
| Equity capital |
2,619
|
2,949
|
26 |
| - share capital |
43
|
47
|
48 |
| Employees (average) |
1
|
2
|
3 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
86.9%
|
60.2%
|
2.8% |
| Turnover per employee |
180
|
21
|
17 |
| Profit as a percentage of turnover |
-50.6%
|
-2271.4%
|
-6422.0% |
| Return on assets (ROA) |
-2.6%
|
-19.3%
|
-340.1% |
| Current ratio |
727.3%
|
425.6%
|
659.7% |
| Return on equity (ROE) |
-3.5%
|
-32.3%
|
-12350.0% |
| Change turnover |
141
|
-7
|
-951 |
| Change turnover % |
364%
|
-14%
|
-95% |
| Chg. No. of employees |
-1
|
-1
|
0 |
| Chg. No. of employees % |
-50%
|
-33%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.